Pathophysiology and Pharmacotherapy of Common Upper Respiratory Diseases
Identifieur interne : 001339 ( Main/Exploration ); précédent : 001338; suivant : 001340Pathophysiology and Pharmacotherapy of Common Upper Respiratory Diseases
Auteurs : Philip Fireman [États-Unis]Source :
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy [ 0277-0008 ] ; 1993-11-12.
Abstract
The response of the upper respiratory tract to many environmental factors can be used both to analyze the body's inflammatory process and to choose appropriate therapy. The nose is the major pathway to the lungs, upper airways, sinuses, middle ears, and other parts of the body, and its reactions often represent a major portion of the problem. The most common upper respiratory illnesses are upper respiratory infections (URIs), primarily viral, followed by secondary bacterial infections. Approximately 20% of the total population may manifest allergic rhinitis, which is mediated by immunoglobulin E. This condition is often referred to as hay fever, although there is no direct allergy to hay, and there is no fever. The differential diagnosis includes nonallergic rhinitis with eosinophils, which mimics the pathophysiology of allergic rhinitis but yields negative results on skin testing; vasomotor and hormonal rhinitis; and rhinitis medicamentosa, the rebound congestion associated with overuse of topical adrenergic agents. Therapeutic options include avoiding causative agents, immunotherapy, and pharmacotherapy. Antihistamines produce excellent results in allergic rhinitis when sneezing and itching are present, but are of minimal value as decongestants. The α‐adrenergic agonists are the optimum choices for congestion associated with viral URIs, and allergic or nonallergic rhinitis. Of major importance are accurate diagnosis, selection of appropriate therapy, and patient compliance.
Url:
DOI: 10.1002/j.1875-9114.1993.tb02778.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000521
- to stream Istex, to step Curation: 000501
- to stream Istex, to step Checkpoint: 000504
- to stream Main, to step Merge: 001355
- to stream Main, to step Curation: 001339
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pathophysiology and Pharmacotherapy of Common Upper Respiratory Diseases</title><author><name sortKey="Fireman, Philip" sort="Fireman, Philip" uniqKey="Fireman P" first="Philip" last="Fireman">Philip Fireman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:60457586211DC9F08FF74DD555DCB4C7A81F7CE1</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1002/j.1875-9114.1993.tb02778.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-SGMFZ1B2-N/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000521</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000521</idno><idno type="wicri:Area/Istex/Curation">000501</idno><idno type="wicri:Area/Istex/Checkpoint">000504</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000504</idno><idno type="wicri:doubleKey">0277-0008:1993:Fireman P:pathophysiology:and:pharmacotherapy</idno><idno type="wicri:Area/Main/Merge">001355</idno><idno type="wicri:Area/Main/Curation">001339</idno><idno type="wicri:Area/Main/Exploration">001339</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Pathophysiology and Pharmacotherapy of Common Upper Respiratory Diseases</title><author><name sortKey="Fireman, Philip" sort="Fireman, Philip" uniqKey="Fireman P" first="Philip" last="Fireman">Philip Fireman</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>School of Medicine, University of Pittsburgh, and Children's Hospital, Pittsburgh</wicri:cityArea></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><placeName><region type="state">Pennsylvanie</region></placeName><wicri:cityArea>Correspondence address: Children's Hospital, 3705 Fifth Avenue, Pittsburgh</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</title><title level="j" type="alt">PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY</title><idno type="ISSN">0277-0008</idno><idno type="eISSN">1875-9114</idno><imprint><biblScope unit="vol">13</biblScope><biblScope unit="issue">6P2</biblScope><biblScope unit="page" from="101S">101S</biblScope><biblScope unit="page" to="109S">109S</biblScope><biblScope unit="page-count">9</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1993-11-12">1993-11-12</date></imprint><idno type="ISSN">0277-0008</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0277-0008</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The response of the upper respiratory tract to many environmental factors can be used both to analyze the body's inflammatory process and to choose appropriate therapy. The nose is the major pathway to the lungs, upper airways, sinuses, middle ears, and other parts of the body, and its reactions often represent a major portion of the problem. The most common upper respiratory illnesses are upper respiratory infections (URIs), primarily viral, followed by secondary bacterial infections. Approximately 20% of the total population may manifest allergic rhinitis, which is mediated by immunoglobulin E. This condition is often referred to as hay fever, although there is no direct allergy to hay, and there is no fever. The differential diagnosis includes nonallergic rhinitis with eosinophils, which mimics the pathophysiology of allergic rhinitis but yields negative results on skin testing; vasomotor and hormonal rhinitis; and rhinitis medicamentosa, the rebound congestion associated with overuse of topical adrenergic agents. Therapeutic options include avoiding causative agents, immunotherapy, and pharmacotherapy. Antihistamines produce excellent results in allergic rhinitis when sneezing and itching are present, but are of minimal value as decongestants. The α‐adrenergic agonists are the optimum choices for congestion associated with viral URIs, and allergic or nonallergic rhinitis. Of major importance are accurate diagnosis, selection of appropriate therapy, and patient compliance.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Pennsylvanie</li></region></list><tree><country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Fireman, Philip" sort="Fireman, Philip" uniqKey="Fireman P" first="Philip" last="Fireman">Philip Fireman</name></region><name sortKey="Fireman, Philip" sort="Fireman, Philip" uniqKey="Fireman P" first="Philip" last="Fireman">Philip Fireman</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001339 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001339 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:60457586211DC9F08FF74DD555DCB4C7A81F7CE1
|texte= Pathophysiology and Pharmacotherapy of Common Upper Respiratory Diseases
}}
| This area was generated with Dilib version V0.6.33. |  |